Bioxcel Therapeutics Inc (BTAI) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 
Bioxcel Therapeutics Inc   (NASDAQ: BTAI)
 

Bioxcel Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bioxcel Therapeutics Inc 's inventory turnover ratio, the ratio that measures Bioxcel Therapeutics Inc 's ability to manage its supply chain, sequentially decreased to 0.64 in the second quarter 2026, which does not come as a surprise, as the Bioxcel Therapeutics Inc continue to experience headwinds, which also impact its supply chain. Bioxcel Therapeutics Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 570 days, from 462 days, in the Mar 31 2026 quarter.

Within Healthcare sector 342 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1493 in the first quarter 2026, to 1874.

BTAI Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bioxcel Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BTAI Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Inventory Growth -4.55 % -22.12 % 6.33 % -69.9 % -81.12 %
Y / Y Cost of Sales Growth -79.44 % 1921.43 % -96.15 % -99.06 % 72.58 %
Inventory Turnover Ratio (TTM) 0.64 0.79 0.28 1.69 2.53
BTAI's Total Ranking # 1874 # 1493 # 1771 # 1043 # 1138
Average inventory processing period 567 461 1296 217 144
Seq. Inventory Growth -3.4 % -30.75 % 57.3 % -9.29 % -21.18 %
Seq. Cost of Sales Growth -92.23 % 784.38 % 190.91 % -89.72 % 664.29 %




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 105
Healthcare Sector # 343
Overall Market # 1874

Inventory Turnover Ratio Statistics
High Average Low
2.53 0.78 0.01
(Jun 30 2025)   (Dec 31 2022)



BTAI Company Profile >> Back to BTAI Efficiency Comparisons >> Compare BTAI Inventory Turnover Ratio to its Competitors

Financial Statements
Bioxcel Therapeutics Inc 's Inventories $ 0 Millions Visit BTAI's Balance sheet
Bioxcel Therapeutics Inc 's Cost of Revenues TTM $ 0 Millions Visit BTAI's Income Statement
What are BTAI's Sales? Visit BTAI's Sales by Segment

Other Inventory Turnover Ratios
Bioxcel Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BTAI's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BTAI's Competitors
Inventory Turnover Ratio for BTAI's Suppliers
Inventory Turnover Ratio for BTAI's Customers

You may also want to know
BTAI's Sales Growth Rates BTAI's Pe Price to earnings ratio BTAI's Receivables Turnover Ratio BTAI's Stock Quote
BTAI's Net Income Growth Rates BTAI's Ps Price to Sales ratio BTAI's Sales per Employee BTAI's Asset Turnover Ratio
BTAI's Net Margin BTAI's Pb Price to Book ratio BTAI's Financial Strength Ratios BTAI's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Clearpoint Neuro Inc   1.96 $ 15.809  Millions$ 8  Millions
Skinhealth Systems Inc   1.95 $ 96.775  Millions$ 50  Millions
Retractable Technologies Inc  1.94 $ 33.979  Millions$ 17  Millions
Intuitive Surgical Inc   1.94 $ 3,676.900  Millions$ 1,899  Millions
Lifeloc Technologies Inc   1.93 $ 5.381  Millions$ 3  Millions
Accuray Incorporated  1.93 $ 290.064  Millions$ 150  Millions
Nature s Sunshine Products inc   1.92 $ 131.811  Millions$ 69  Millions
Insulet Corporation  1.91 $ 883.000  Millions$ 462  Millions
Innoviva Inc   1.91 $ 74.000  Millions$ 39  Millions
Cytek Biosciences Inc   1.90 $ 96.247  Millions$ 51  Millions
Immucell Corporation  1.89 $ 17.409  Millions$ 9  Millions
Pacific Biosciences Of California Inc   1.89 $ 101.369  Millions$ 54  Millions
Safe Pro Group Inc   1.88 $ 1.089  Millions$ 1  Millions
Rigel Pharmaceuticals Inc  1.88 $ 23.839  Millions$ 13  Millions
Sunshine Biopharma Inc   1.87 $ 24.637  Millions$ 13  Millions
Amgen Inc   1.86 $ 11,613.000  Millions$ 6,244  Millions
Ocular Therapeutix Inc   1.84 $ 6.708  Millions$ 4  Millions
Trisalus Life Sciences Inc   1.82 $ 6.508  Millions$ 4  Millions
Halozyme Therapeutics Inc   1.79 $ 292.421  Millions$ 164  Millions
Seastar Medical Holding Corp  1.78 $ 0.126  Millions$ 0  Millions
Alpha Pro Tech Ltd   1.76 $ 38.696  Millions$ 22  Millions
Tenet Healthcare Corp  1.76 $ 605.000  Millions$ 344  Millions
Tenon Medical Inc   1.76 $ 1.763  Millions$ 1  Millions
Iradimed Corporation  1.76 $ 20.839  Millions$ 12  Millions
Utah Medical Products Inc  1.75 $ 14.771  Millions$ 8  Millions
Elutia Inc   1.75 $ 4.337  Millions$ 2  Millions
Axsome Therapeutics Inc   1.73 $ 52.530  Millions$ 30  Millions
Vycor Medical Inc   1.72 $ 0.301  Millions$ 0  Millions
Harvard Bioscience Inc   1.71 $ 37.097  Millions$ 22  Millions
Quanterix Corporation  1.69 $ 87.760  Millions$ 52  Millions

Date modified: 2026-09-03T11:36:13+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.